Expansion of human megakaryocyte-biased hematopoietic stem cells by biomimetic Microniche.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37072407.
- Also identified by DOI 10.1038/s41467-023-37954-3 and PMC identifier 10113370.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Limited numbers of available hematopoietic stem cells (HSCs) limit the widespread use of HSC-based therapies. Expansion systems for functional heterogenous HSCs remain to be optimized. Here, we present a convenient strategy for human HSC expansion based on a biomimetic Microniche. After demonstrating the expansion of HSC from different sources, we find that our Microniche-based system expands the therapeutically attractive megakaryocyte-biased HSC. We demonstrate scalable HSC expansion by applying this strategy in a stirred bioreactor. Moreover, we identify that the functional human megakaryocyte-biased HSCs are enriched in the CD34<sup>+</sup>CD38<sup>-</sup>CD45RA-CD90<sup>+</sup>CD49f <sup>low</sup>CD62L<sup>-</sup>CD133<sup>+</sup> subpopulation. Specifically, the expansion of megakaryocyte-biased HSCs is supported by a biomimetic niche-like microenvironment, which generates a suitable cytokine milieu and supplies the appropriate physical scaffolding. Thus, beyond clarifying the existence and immuno-phenotype of human megakaryocyte-biased HSC, our study demonstrates a flexible human HSC expansion strategy that could help realize the strong clinical promise of HSC-based therapies.
Medical subject headings
- Megakaryocytes
- Biomimetics